ENANTA PHARMACEUTICALS, INC (ENTA) Operating cash flow 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$19.3MFY2025 · since FY2017: $52.7M → -$19.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.3M | +75.5% |
| FY2024 | -$78.8M | +23.6% |
| FY2023 | -$103.2M | -21.7% |
| FY2022 | -$84.8M | -21.1% |
| FY2021 | -$70.0M | -1087.5% |
| FY2020 | $7.1M | -90.1% |
| FY2019 | $71.4M | +144.4% |
| FY2018 | $29.2M | -44.5% |
| FY2017 | $52.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTA financial trends
ENTA RevenueENTA Net incomeENTA Net marginENTA Gross profitENTA Gross marginENTA Operating incomeENTA Operating marginENTA Free cash flowENTA Capital expendituresENTA Return on equityENTA Stock buybacksENTA Dividends paidENTA Total assetsENTA Total liabilitiesENTA Shareholders’ equityENTA overview →